1. 2‐Hydroxypropyl‐β‐cyclodextrin reduces retinal cholesterol in wild‐type and Cyp27a1−/−Cyp46a1−/− mice with deficiency in the oxysterol production. (13th August 2020) Authors: El‐Darzi, Nicole; Mast, Natalia; Petrov, Alexey M.; Pikuleva, Irina A. Journal: British journal of pharmacology Issue: Volume 178:Number 16(2021) Page Start: 3220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes. Issue 1 (11th April 2020) Authors: Petrov, Alexey M; Mast, Natalia; Li, Young; Denker, John; Pikuleva, Irina A Journal: Brain communications Issue: Volume 2:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cholesterol Hydroperoxides as Substrates for Cholesterol‐Metabolizing Cytochrome P450 Enzymes and Alternative Sources of 25‐Hydroxycholesterol and other Oxysterols. (29th July 2015) Authors: van Lier, Johan E.; Mast, Natalia; Pikuleva, Irina A. Journal: Angewandte Chemie Issue: Volume 127:Number 38(2015) Page Start: 11290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cholesterol Hydroperoxides as Substrates for Cholesterol‐Metabolizing Cytochrome P450 Enzymes and Alternative Sources of 25‐Hydroxycholesterol and other Oxysterols. Issue 38 (29th July 2015) Authors: van Lier, Johan E.; Mast, Natalia; Pikuleva, Irina A. Journal: Angewandte Chemie international edition Issue: Volume 54:Issue 38(2015) Page Start: 11138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease. (1st September 2017) Authors: Mast, Natalia; Saadane, Aicha; Valencia-Olvera, Ana; Constans, James; Maxfield, Erin; Arakawa, Hiroyuki; Li, Young; Landreth, Gary; Pikuleva, Irina A. Journal: Neuropharmacology Issue: Volume 123(2017) Page Start: 465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CYP46A1-dependent and independent effects of efavirenz treatment. Issue 2 (29th October 2020) Authors: Mast, Natalia; El-Darzi, Nicole; Petrov, Alexey M; Li, Young; Pikuleva, Irina A Journal: Brain communications Issue: Volume 2:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Histone H3 Ser57 and Thr58 phosphorylation in the brain of 5XFAD mice. Issue 1 (25th June 2015) Authors: Anderson, Kyle W.; Mast, Natalia; Pikuleva, Irina A.; Turko, Illarion V. Journal: FEBS open bio Issue: Volume 5:Issue 1(2015) Page Start: 550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Misdiagnosis of CTX due to propofol: The interference of total intravenous propofol anaesthesia with bile acid profiling. Issue 4 (7th February 2020) Authors: Claesen, Joep L. A.; Koomen, Erik; Schene, Imre F.; Jans, Judith J. M.; Mast, Natalia; Pikuleva, Irina A.; van der Ham, Maria; de Sain‐van der Velden, Monique G. M.; Fuchs, Sabine A. Journal: Journal of inherited metabolic disease Issue: Volume 43:Issue 4(2020) Page Start: 843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Synthesis and pharmacokinetic study of a 11C-labeled cholesterol 24-hydroxylase inhibitor using 'in-loop' [11C]CO2 fixation method. Issue 9 (1st May 2020) Authors: Chen, Zhen; Chen, Jiahui; Mast, Natalia; Rong, Jian; Deng, Xiaoyun; Shao, Tuo; Fu, Hualong; Yu, Qingzhen; Sun, Jiyun; Shao, Yihan; Josephson, Lee; Collier, Thomas Lee; Pikuleva, Irina; Liang, Steven H. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 30:Issue 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The key genes, phosphoproteins, processes, and pathways affected by efavirenz‐activated CYP46A1 in the amyloid‐decreasing paradigm of efavirenz treatment. Issue 8 (7th May 2019) Authors: Petrov, Alexey M.; Mast, Natalia; Li, Yong; Pikuleva, Irina A. Journal: FASEB journal Issue: Volume 33:Issue 8(2019) Page Start: 8782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗